These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


257 related items for PubMed ID: 26468535

  • 21. Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
    Liang B, Munir S, Amaro-Carambot E, Surman S, Mackow N, Yang L, Buchholz UJ, Collins PL, Schaap-Nutt A.
    J Virol; 2014 Apr; 88(8):4237-50. PubMed ID: 24478424
    [Abstract] [Full Text] [Related]

  • 22. CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.
    Green G, Johnson SM, Costello H, Brakel K, Harder O, Oomens AG, Peeples ME, Moulton HM, Niewiesk S.
    J Virol; 2021 Jul 26; 95(16):e0001021. PubMed ID: 34037420
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus.
    Rawling J, Cano O, Garcin D, Kolakofsky D, Melero JA.
    J Virol; 2011 Mar 26; 85(6):2771-80. PubMed ID: 21228237
    [Abstract] [Full Text] [Related]

  • 27. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D, Phan S, DiStefano DJ, Citron MP, Callahan CL, Indrawati L, Dubey SA, Heidecker GJ, Govindarajan D, Liang X, He B, Espeseth AS.
    J Virol; 2017 Jun 01; 91(11):. PubMed ID: 28298602
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines.
    King T, Mejias A, Ramilo O, Peeples ME.
    PLoS Pathog; 2021 Apr 01; 17(4):e1009469. PubMed ID: 33831114
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion.
    Huang K, Incognito L, Cheng X, Ulbrandt ND, Wu H.
    J Virol; 2010 Aug 01; 84(16):8132-40. PubMed ID: 20519399
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.
    Chirkova T, Lin S, Oomens AGP, Gaston KA, Boyoglu-Barnum S, Meng J, Stobart CC, Cotton CU, Hartert TV, Moore ML, Ziady AG, Anderson LJ.
    J Gen Virol; 2015 Sep 01; 96(9):2543-2556. PubMed ID: 26297201
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
    Liang B, Surman S, Amaro-Carambot E, Kabatova B, Mackow N, Lingemann M, Yang L, McLellan JS, Graham BS, Kwong PD, Schaap-Nutt A, Collins PL, Munir S.
    J Virol; 2015 Sep 01; 89(18):9499-510. PubMed ID: 26157122
    [Abstract] [Full Text] [Related]

  • 40. Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus.
    Olmsted RA, Buller RM, Collins PL, London WT, Beeler JA, Prince GA, Chanock RM, Murphy BR.
    Vaccine; 1988 Dec 01; 6(6):519-24. PubMed ID: 3072795
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.